Non-ownership Filings
| Change of Registered Address | Apr. 20, 2026 |
| Result of General Meeting and Change of Name | Mar. 17, 2026 |
| Notice of GM and Proposed Change of Name | Feb. 27, 2026 |
| CEO Appointment & Name Change Thalia Therapeutics | Feb. 24, 2026 |
| Partnership with University of Strathclyde’s CMAC | Sep. 23, 2025 |
| N4 Pharma’s Nuvec® Targets Lung Cancer Cells | Sep. 22, 2025 |
| Investor Event and Presentation | Sep. 11, 2025 |
Ownership Update Filings
| TR-1: Notification of major holdings | May. 23, 2025 |
| Holding(s) in Company | May. 21, 2025 |
| Holding(s) in Company | May. 09, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 28, 2025 |
| TR-1: Standard form notification of major holdings | Apr. 23, 2025 |